HIV racial disparities noted for men who have sex with men
Similar racial disparities are seen in HIV infection for men who have sex with men in the United States and the United Kingdom, according to a study published online July 20 in The Lancet.
(HealthDay) -- Similar racial disparities are seen in HIV infection for men who have sex with men (MSM) in the United States and the United Kingdom, according to a study published online July 20 in The Lancet.
Gregorio A. Millett, M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues conducted a meta-analysis to assess factors associated with disparities in HIV infection in black MSM. Seven studies from Canada, 13 from the United Kingdom, and 174 from the United States were included, involving 106,148 black MSM and 581,577 other MSM.
In every country, the researchers found that black MSM were as likely as other MSM to engage in serodiscordant unprotected sex. U.S. and Canadian black MSM were significantly less likely to have a history of substance abuse, compared with other MSM. U.S. and U.K. black MSM were more likely to be HIV-positive, and black HIV-positive MSM were less likely to initiate combination antiretroviral therapy (cART). Compared with other U.S. HIV-positive MSM, black HIV-positive MSM were less likely to have health insurance, adhere to cART, be virally suppressed, and have a high CD4 count. U.S. black MSM were significantly more likely than others to report any preventive behavior against HIV infection, despite having increased odds of any structural barrier that increases HIV risk. For black versus other U.S. MSM, disparities for HIV outcomes were greatest for structural barriers, sex partner demographics, and HIV care outcomes, and were least for sexual risk outcomes.
"Elimination of disparities in HIV infection in black MSM cannot be accomplished without addressing structural barriers or differences in HIV clinical care access and outcomes," the authors write.
More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Journal reference:
The Lancet
Copyright © 2012 HealthDay. All rights reserved.
-
Higher HIV risk in black gay men linked to partner choice, risk perception
May 02, 2011 |
not rated yet |
0
-
HIV 'epidemics' emerging in MENA region: study
Aug 03, 2011 |
not rated yet |
0
-
Black gay men are more affected by AIDS than any population in the developed world
Jul 18, 2012 |
not rated yet |
0
-
Study finds HIV-infected men at risk for spreading HIV despite taking HAART
Mar 27, 2012 |
not rated yet |
0
-
High HIV infection rate among Soweto Township gays
Aug 31, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Integrating mental health care into HIV care
The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...
HIV & AIDS
9 hours ago |
not rated yet |
0
After a decade, global AIDS program looks ahead
(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...
HIV & AIDS
22 hours ago |
not rated yet |
0
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
HIV & AIDS
May 19, 2013 |
5 / 5 (1) |
0
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
HIV & AIDS
May 18, 2013 |
5 / 5 (2) |
0
Peer-referral programs can increase HIV-testing in emergency departments
Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...
HIV & AIDS
May 17, 2013 |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.